0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Endocrinology > Diabetes

Buy Now

Drug Development for Cancer and Diabetes - A Path to 2030 (Paperback) Loot Price: R2,447
Discovery Miles 24 470
Drug Development for Cancer and Diabetes - A Path to 2030 (Paperback): K. Saravanan, Chukwuebuka Egbuna, Horne Iona Averal, S....

Drug Development for Cancer and Diabetes - A Path to 2030 (Paperback)

K. Saravanan, Chukwuebuka Egbuna, Horne Iona Averal, S. Kannan, S. Elavarasi, Bir Bahadur

 (sign in to rate)
Loot Price R2,447 Discovery Miles 24 470 | Repayment Terms: R229 pm x 12*

Bookmark and Share

Expected to ship within 9 - 15 working days

Key features include: Details the role of plants for the treatment and management of cancer and diabetes Discusses the role of phytocompounds as ligands for cancer and diabetic targets Reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs Explores the green biosynthesis of nanoparticles and their treatment efficiency

General

Imprint: Apple Academic Press Inc.
Country of origin: Canada
Release date: February 2022
First published: 2021
Editors: K. Saravanan • Chukwuebuka Egbuna • Horne Iona Averal • S. Kannan • S. Elavarasi • Bir Bahadur
Dimensions: 234 x 156 x 24mm (L x W x T)
Format: Paperback
Pages: 362
ISBN-13: 978-1-77463-493-6
Categories: Books > Medicine > Clinical & internal medicine > Endocrinology > Diabetes
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-77463-493-7
Barcode: 9781774634936

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners